Gain Therapeutics Revenue Growth & History (GANX)

Gain Therapeutics reported $55,180 in revenue for fiscal 2023, a decrease of 58.40% from the previous fiscal year.

View full Gain Therapeutics company overview

Gain Therapeutics annual revenue and growth

Gain Therapeutics annual revenue

Fiscal yearPeriod endedRevenueChangeGrowth
20232023-12-31$55,180−$77,460−58.40%
20222022-12-31$132,640−$1,288−0.96%
20212021-12-31$133,928$105,047+363.72%
20202020-12-31$28,881
About the data

What revenue means

Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.

Primary source

SEC company filings

TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.

Review Gain Therapeutics filings at SEC.gov ↗